Literature DB >> 6989401

Cell transformation as a model for tumor induction and neoplastic growth.

L A Smets.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989401     DOI: 10.1016/0304-419x(80)90022-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  7 in total

1.  Cell culture studies on neurofibromatosis (von Recklinghausen's disease). IV. Collagen synthesis.

Authors:  O Mühleck; W Krone; R Mao; L Weber
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Carcinogen- and radiation-transformed C3H 10T1/2 cells contain RNAs homologous to the long terminal repeat sequence of a murine leukemia virus.

Authors:  P Kirschmeier; S Gattoni-Celli; D Dina; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Cell culture studies on neurofibromatosis (von Recklinghausen). I. Comparative growth experiments with fibroblasts at high and low concentrations of fetal calf serum.

Authors:  W Krone; S Zörlein; R Mao
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs.

Authors:  G V Glinsky; V V Mossine; J E Price; D Bielenberg; V V Glinsky; H N Ananthaswamy; M S Feather
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

Review 5.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Hexose transport in Epstein-Barr virus (EBV) negative lymphoma lines and their EBV converted, virus genome carrying sublines.

Authors:  W Siegert; T Mönch
Journal:  Blut       Date:  1981-11

7.  p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.

Authors:  J Brugarolas; R T Bronson; T Jacks
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.